RegulatoryJul 20, 2026, 08:16 AM
Tenon Medical Regains Nasdaq Stockholders' Equity Compliance
AI Summary
Tenon Medical, Inc. announced it received notice from Nasdaq on July 17, 2026, confirming it has regained compliance with the Nasdaq Stockholders' Equity Rule. This compliance was achieved following the completion of a $4.2 million public offering of common stock and warrants on July 1, 2026. The company had previously disclosed its belief of compliance in a July 10, 2026 8-K filing. However, Tenon Medical must evidence continued compliance upon filing its Quarterly Report on Form 10-Q for the period ending September 30, 2026, to avoid potential delisting.
Key Highlights
- Tenon Medical regained compliance with Nasdaq Stockholders’ Equity Rule.
- Notice of compliance received from Nasdaq on July 17, 2026.
- Compliance achieved following a $4.2 million public offering of common stock and warrants.
- Public offering was completed on July 1, 2026.
- Company must evidence compliance in Q3 2026 10-Q to avoid potential delisting.
Price Impact
More from TNON